Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain

Abstract 1-acetyl,2-docosahexaenoyl-glycerophosphocholine (AceDoPC) has been made to prevent docosahexaenoyl (DHA) to move to the sn-1 position as it rapidly does when present in 1-lyso,2-docosahexaenoyl-GPC (lysoPC-DHA), an efficient DHA transporter to the brain. When incubated with human blood, Ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 2015-01, Vol.92, p.63-65
Hauptverfasser:	Lagarde, M, Hachem, M, Bernoud-Hubac, N, Picq, M, Véricel, E, Guichardant, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced Basic Science Animals Blood–brain barrier Brain - drug effects Brain - metabolism Brain - pathology Endocrinology & Metabolism Food and Nutrition Humans Life Sciences Metabolism Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Phosphatidylcholines - pharmacology Phosphatidylcholines - therapeutic use Phospholipids - metabolism Stroke Stroke - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!